NCT02282215 2018-09-27
Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia
Cellerant Therapeutics
Phase 2 Completed
Cellerant Therapeutics
Janssen Korea, Ltd., Korea
Janssen Korea, Ltd., Korea
Enzon Pharmaceuticals, Inc.